Results 151 to 160 of about 1,492,137 (202)

Brainstem Encephalitis Following COVID-19 Vaccination: A Case Report. [PDF]

Cureus
Koseki A, Suzuki Y, Uchida S, Morishita N, Sakai N.   +4 more
europepmc   +1 more source

Recombinant Japanese Encephalitis Virus Envelope Antigen Presented on CoPoP Liposomes Elicits Cellular Immunity and Protects Mice From Lethal Challenge. [PDF]

Immune Netw
Kim SY, Jung IR, Park H, Choi JO, Kim SH, Pak J, Kim J, Choi C, Kwon SY, Jeong K, Kim N, Kim J, Nam KT, Jeong DG, Shim DH, Lee JM, Kang JM, Hwang SS, Lee JY.   +18 more
europepmc   +1 more source

Meningitis: is vaccine introduction enough? [PDF]

Lancet Reg Health Southeast Asia
The Lancet Regional Health-Southeast Asia.
europepmc   +1 more source

Qualitative risk assessment of Japanese encephalitis virus introduction and transmission in Pacific Island countries and territories. [PDF]

PLoS Negl Trop Dis
Skinner EB, Murphy AK, Yu F, Moore KT, Chen-Cao L, Williams DT, Karl S, Goi J, Lau CL, Sartorius B.   +9 more
europepmc   +1 more source

Japanese encephalitis vaccines.

Releve epidemiologique hebdomadaire, 1999
openaire   +1 more source

Japanese encephalitis vaccines.

Releve epidemiologique hebdomadaire, 2006
openaire   +1 more source

Japanese encephalitis vaccine in travelers

Expert Review of Vaccines, 2008
Extensive vaccination against Japanese encephalitis (JE) has been carried out in many Asian countries for the past 20 years and is also increasingly recommended for travelers to endemic areas. Concerns have been raised regarding potential neurological and allergic side effects of the currently available JE vaccine, which is manufactured from mouse ...
Tomáš Jelínek
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

IC51 Japanese Encephalitis vaccine

Expert Opinion on Biological Therapy, 2009
Japanese encephalitis is the leading cause of viral encephalitis in Asia. Every year 30,000 - 50,000 cases and 10,000 deaths from Japanese encephalitis are reported, and underreporting has been suggested. No effective antiviral therapy exists to treat this mosquito-borne flavivirus infection. For active immunization vaccines are available.
Herwig Kollaritsch, Maria Paulke-Korinek
exaly   +3 more sources

Recent developments in vaccines and biological therapies against Japanese encephalitis virus

Expert Opinion on Biological Therapy, 2018
Japanese encephalitis is the most common vaccine-preventable encephalitis in the Asia-Pacific region. Areas covered: We provide an overview on Japanese encephalitis virus and associated disease, review the results of studies on the immunogenicity and ...
Giorgio Palù, Luisa Barzon
exaly   +2 more sources